NCT02929459View on ClinicalTrials.gov

Effects of Riboflavin on Faecalibacterium Prausnitzii and the Gut Microbiota

PHASE2CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

November 1, 2016

Primary Completion Date

October 1, 2018

Study Completion Date

December 1, 2019

Conditions
Gut Microbiota
Interventions
DIETARY_SUPPLEMENT

Riboflavin Dose 1

DIETARY_SUPPLEMENT

Riboflavin Dose 2

OTHER

Placebo

Trial Locations (1)

9713

Medical Microbiology, UMCG Groningen, Groningen

All Listed Sponsors
lead

DSM Nutritional Products, Inc.

INDUSTRY

NCT02929459 - Effects of Riboflavin on Faecalibacterium Prausnitzii and the Gut Microbiota | Biotech Hunter | Biotech Hunter